Harvard Bioscience, Inc. - Common Stock — Bilancio Trimestrale (NASDAQ:HBIO)

Harvard Bioscience, Inc. - Common Stock

Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company's brands include: Biochrom, BTX, CMA, Data Sciences International, Harvard Apparatus, HEKA, Hugo Sachs Elektronik, KD Scientific, Multi Channel Systems, Panlab, and Warner Instruments. The company has approximately 355 employees, with 216 of those in the USA, and its principal manufacturing facilities are in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany.

HBIO

Financials

Harvard Bioscience, Inc. - Common Stock

Notizie

Relazione sugli utili: Harvard Bioscience manca le previsioni del Q1 2026

Relazione sugli utili: Harvard Bioscience manca le stime EPS nel Q1 2026, titolo in calo

Il CFO di Harvard Bioscience Frost acquista azioni HBIO per 25.000$

Il direttore di Harvard Bioscience Snider acquista azioni HBIO per 103.603$

Benchmark alza il target su Harvard Bioscience a $6 dopo il reverse split

Benchmark raises Harvard Bioscience stock price target to $6 on reverse split

Benchmark riduce il target di Harvard Bioscience per timori NIH

Benchmark cuts Harvard Bioscience stock price target on NIH concerns

Harvard Bioscience, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:HBIO) 2026-03-13

Harvard Bioscience Q4 2025: margini ai massimi di 7 trimestri

Harvard Bioscience Q4 2025 slides: margins hit 7-quarter high

Gli EPS di Harvard Bioscience hanno mancato le aspettative per 0,10$, il fatturato supera le previsioni